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Summary
Emerging evidences suggest that cyclin-dependent kinase inhibitors (CKIs) can regulate cellular functions other than cell
cycle progression, such as differentiation and migration. Here, we report that cytoplasmic expression of p27kip1 affects
microtubule (MT) stability following cell adhesion on extracellular matrix (ECM) constituents. This p27kip1 activity is due to
its ability to bind and impair the function of the MT-destabilizing protein stathmin. Accordingly, upregulation of p27kip1 or
downregulation of stathmin expression results in the inhibition of mesenchymal cell motility. Moreover, high stathmin and
low cytoplasmic p27kip1 expression correlate with the metastatic phenotype of human sarcomas in vivo. This study provides
a functional link between proliferation and invasion of tumor cells based on diverse activities of p27kip1 in different subcellular
compartments.
Introduction cell adhesion or motility on ECM substrates has been proposed
(Juliano, 2003). Similarly, data from different laboratories sug-
The tight crosstalk that exists between cells and surrounding gest that CKIs can exert additional physiological functions, not
extracellular matrix (ECM) components influences both cell exclusively dependent on their ability to bind and inhibit the
growth and survival. ECMalso provides background information cyclin-CDK complexes (Ohnuma et al., 1999; Baldassarre et al.,
and architectural scaffold for cellular adhesion and migration, 1999a; Goukassian et al., 2001; Sun et al., 2001). It is now
eventually affecting the behavior of both normal and neoplastic accepted that CKI nuclear localization is of primary importance
cells (Bissell and Radisky, 2001). Signals from the ECM are for the control of cell cycle progression (reviewed in Blain et al.,
transducedmainly froma family of glycoproteins called integrins 2003), yet in both normal and tumor cells CKIs can shuttle from
(reviewed in Hood and Cheresh, 2002) that activate several the nucleus to the cytoplasm, suggesting that the same protein
intracytoplasmic pathways, resulting in the formation of focal exerts additional activities in different subcellular compart-
adhesion contacts and cytoskeleton reorganization, finally lead- ments. Among the cell cycle regulators an important role has
ing to cell cycle progression (reviewed in Giancotti and Ruos- been recently proposed for the CKI p27kip1 (hereafter p27) in the
lahti, 1999). It is well established that integrin stimulation is regulation of cell motility. p27 seems to act as an inhibitor of
necessary for the correct proliferation of adhesion-dependent cell motility directed by chemotactic or aptotactic stimuli in
growing cells. The observation that adhesion to ECM directly smoothmuscle (Sun et al., 2001), mesangial (Daniel et al., 2004),
influences the expression levels of cyclin D1 or of the CDK and endothelial cells (Goukassian et al., 2001), although the
inhibitor (CKI) p27kip1 proteins (reviewed in Schwartz and As- precise molecular mechanism is still unclear.
In transformed cells, the low expression levels of p27 proteinsoian, 2001) provides amolecular explanation for this phenome-
non. More recently, a role for cell cycle-regulating proteins in are strictly linked to patients’ survival in many types of examined
S I G N I F I C A N C E
This study explores the relationship between cell cycle regulation and cell adhesion and motility through or within the ECM, both of
which represent important issues in several pathological alterations such as tumor invasion and metastatization. Here, we describe
a pathway that links p27kip1 nucleocytoplasmic shuttling and the regulation of MT stability by stathmin, pointing to MT dynamics as
an important determinant of cell motility and, more generally, of cancer cells’ invasion and metastatization potential. Moreover,
the finding that in mammalian cells a CKI contributes to regulate MT stability during interphase strictly connects the regulation of
proliferation to the control of cell migration in both normal and tumor cells.
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tumors (reviewed in Slingerland and Pagano, 2000). Moreover, nuclear in migrated cells (downside of the membrane), whereas
EGFP-p27NLS was predominantly nuclear on both sides of thein several types of cancer, such as colon (Thomas et al., 1998)
membrane (Supplemental Figures S1A and S1B at http://www.and bladder carcinomas (Lacoste-Collin et al., 2002) or liposar-
cancercell.org/cgi/content/full/7/1/51/DC1/). Overall, thesecoma (Oliveira et al., 2000), the absence of p27 has been linked
data strongly suggest that cytoplasmic localization of p27 is ato invasion or metastasis. By contrast, the only functional study
prerequisite for its inhibition of cell migration.that is available reports an increased scatter motility in HepG2
Immortalized mouse fibroblasts derived from wild-type (wt)hepatoma cells following transduction with a TAT-p27 fusion
or p27 null embryos were serum starved and then allowed toprotein (McAllister et al., 2003).
migrate through FN-coated membranes for up to 6 hr. UnderTaking into account that the role of p27 in cell migration is
these experimental conditions, p27 null cells migrated throughstill controversial and the mechanisms of action in normal as
FN at a 2-fold faster rate with respect to controls (Figure 1F).well as in cancer cells remain poorly elucidated, we investigated
Similar results were obtained using wt or null p27 primary MEFsthe influence of p27 on cell migration induced by cell-ECM
(Supplemental Figure S1C at http://www.cancercell.org/cgi/contact. The present results demonstrate that p27 expression
content/full/7/1/51/DC1/). Moreover, reduction of p27 expres-inhibits cell motility and that this activity depends on the ability
sion with p27 antisense oligodeoxynucleotide (AS ODN) into bind to and limit the function of the microtubule (MT)-destabi-
p27/ fibroblasts (Figure 1F, inset) resulted in a 2-fold increaselizing protein stathmin in the cell cytoplasm.
of cell migration through FN (Figure 1F). All these results strongly
point to a physiological role of p27 in cell migration inhibition.Results
Importantly, adhesion of serum-starved fibroblasts to FN in-
duced a prompt nucleocytoplasmic shuttling, as revealed byp27 inhibits ECM-driven cell migration
Western blot and IF analysis (Supplemental Figures S1D andThe fibrosarcoma HT-1080 cells display a high rate of migration
S1E). On the contrary, p27 was mainly nuclear when cells wereon ECM substrates in vitro through fibronectin (FN)- or vitronec-
either serum starved or in suspension (Supplemental Figurestin (VN)-coated membranes (Figure 1A and data not shown),
S1D and S1E), demonstrating that detachment per se did notthus representing a good in vitro model for motility studies. HT-
alter p27 localization and further confirming the requirement of1080 were stably transfected with an expression vector encod-
p27 cytoplasmic localization for cell motility inhibition.ing for the human p27wt cDNA. Four cell clones expressing
different amounts of p27 protein (Figure 1B) were tested in
The C-terminal portion of p27 is requireda standard assay to evaluate migration as a function of time
for migration inhibition(Spessotto et al., 2002). Overexpression of p27 reduced the
Although the p27-dependent migration inhibition seemed to bemigration through FN-coated membranes by more than 50%
associated to its cytoplasmic localization, a p27 mutant (EGFP-after 3 and 4 hr and almost completely during the first hour of
p271-150) that lacks its NLS and thus is mainly retained in theincubation. The migration inhibition exerted by p27 correlated
cytoplasm (Baldassarre et al., 1999b; Figure 2A) failed to inhibitwith p27 expression levels, suggesting that p27 acts in a dose-
cell migration (Figures 2B and 2C). The characterization of sev-dependent manner (Figures 1A and 1B). Similarly, when VN was
eral p27 deletion mutants (Figure 2A) led to the identification ofused as a substrate, 60%  7% of parental HT-1080 and only
the last 28 amino acids (p271-170) as the necessary sequence35%  3% and 25%  5% of HT-1080 p27 clones B9 and
for the migration inhibition activity (Figures 2B–2D). p27wt andD11 migrated within 3 hr, respectively (data not shown). These
p271-170 mutant displayed similar growth inhibition activity eitherobservations were confirmed using the green fluorescent fused
in growing cells (Supplemental Figures S2A–S2C at http://proteins (EGFP) to track transiently transfected cells during mi-
www.cancercell.org/cgi/content/full/7/1/51/DC1/) or followinggration. EGFP-p27wt, but not EGFP alone, strongly inhibited
adhesion on FN (Supplemental Figures S2D–S2E). Moreover,
migration of HT-1080 cells through either FN or VN (Figure 1C
they displayed similar ability to bind cyclin A and cdk2 (Supple-
and data not shown). Similarly, both EGFP- or Flag-tagged p27wt mental Figure S2F) or cyclin B1 and CDK1 (data not shown)
proteins inhibited the motility of two other cell lines (Flow-6000 and were similarly displaced in the cytoplasm following cell
and SKUT-1; data not shown). In HT-1080 cells, exogenous p27 adhesion to FN (Supplemental Figure S2G). Stable transduction
was expressed both in the cytoplasm and in the nucleus (Figure of p27 null fibroblasts with p27wt or p271-170 retroviral vectors
1A), raising the question of which fraction was responsible for led to the expression of exogenous proteins at levels that were
the inhibition of cell motility. Thus, EGFP-p27-transfected HT- comparable to the expression of p27 observed in wt fibroblasts
1080 cells were treated for 3 hr with leptomycin B (LMB), an (Supplemental Figures S3A and S3B). The proliferation of the
inhibitor of nuclear export that determines p27 nuclear accumu- different cell lines was similar in the different conditions tested
lation (Ishida et al., 2002). LMB treatment strongly reduced cyto- (Supplemental Figures S3C and S3D), whereas only p27wt pro-
plasmic localization of p27 (data not shown) and severely im- tein expression was able to inhibit cell motility through FN (Sup-
paired p27-mediated migration inhibition, whereas it did not plemental Figure S3E). Altogether, these results indicated that
affect the motility of EGFP-transfected cells (Figure 1C). In addi- p27 can inhibit cell migration when localized in the cytoplasm
tion, an EGFP-p27 fusion protein that, carrying the nuclear local- and when the cyclin-CDK binding sites and the last 28 amino
ization signal (NLS) of the SV40 large antigen (EGFP-p27NLS), acids are conserved. Interestingly, the p27-induced cell cycle
remained mainly located in the nucleus (Figure 1D) almost com- arrest is not sufficient to explain its function on cell migration.
pletely failed to block cell motility (Figure 1E). We next examined
p27 localization onboth sides of Fluoroblokmembranes through p27 expression interferes with cell motility
which HT-1080 cells transfected with EGFP-p27 vectors mi- but not with cell adhesion on ECM substrates
grated for 3 hr. EGFP-p27wt was mainly cytoplasmic in nonmi- To test the possibility that inhibition of migration was the conse-
quence of a defect in the number of cells adhered to the ECM,grated cells (upper side of the membrane) and almost always
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Figure 1. Cytoplasmic p27 inhibits cell migration
A and B: Percentage of migrated parental or
p27-transfected HT-1080 cells through FN (A) and
their p27 expression (B). -tubulin and Hmga1
were used as control for the cytoplasmic (C) and
nuclear (N) fractions, respectively.
C: Percentage inhibition of EFGP and EGFP-p27wt
in migrated cells through FN-coated mem-
branes, treated with LMB or not.
D: Expression and localization of EGFP-p27wt or
EGFP-p27NLS proteins evaluated using anti-EGFP
or anti-p27 abs. Vinculin (cytoplasm) and Lamin
A (nucleus) were used as controls.
E: Percentage inhibition of EGFP-p27wt or EGFP-
p27NLS migrated cells through FN.
F: Percentage of p27 wt, p27 null, or p27 wt fi-
broblasts treated with p27 missense (MS) or anti-
sense (AS) ODN migrated through FN. (Inset) Ex-
pression of p27 and vinculin (loading control) in
MS- or AS ODN-treated cells. The data (SD) rep-
resent the mean of at least three independent
experiments.
we compared the adhesion levels of HT-1080 cells, of two p27- munoprecipitation (co-IP) analysis showed that p27wt interacted
in vivo with stathmin and that this interaction was severely im-derived cell clones, and of p27 wt and null cells. Expression of
p27 had no effect on the adhesion of HT-1080 cells (Figure 2E) paired by the deletion of the last 27 amino acids of p27 (Figure
3A). Stathmin is a ubiquitous protein expressed at highest levelsor of mouse fibroblasts (Figure 2F) on several ECM substrates.
Moreover, transient transfection experiments demonstrated that in brain, which peaks in the neonatal period and decreases in
adult life (Koppel et al., 1990). Consequently, stathmin wasEGFP-p27wt and EGFP-p271-170 did not influence adhesion of
HT-1080 cells assayed over the time (from 5 to 90 min of adhe- readily co-IP with p27 from mouse fetal brain (day 18 p.c.)
(Figure 3B). Stathmin and p27 associated in adult pork brain,sion) (Figure 2G), or by FN titration from 0.5 to 10 g/ml (Figure
2H), thus demonstrating that adhesion on ECM substrates was in mouse fibroblasts adherent to FN but not in serum-starved
cells (Supplemental Figures S4A and S4B at http://www.not quantitatively compromised by p27 expression.
cancercell.org/cgi/content/full/7/1/51/DC1/), suggesting a
physiological role for p27-stathmin interaction.p27 interacts with the MT-destabilizing
protein stathmin
Based on the above results, we speculated that the C terminus p27 counteracts the tubulin sequestering activity
of stathmin in vitroof p27 could be the binding site for proteins involved in the
regulation of cell motility. Hence, using a p27 fragment con- Since stathmin is a MT-destabilizing protein (Cassimeris, 2002),
we tested the effects of p27-stathmin interaction in an in vitrotaining the last 100 amino acids (aa 98–198) as bait in a yeast
two-hybrid screen, we identified the MT-destabilizing protein tubulin polymerization assay. Purified bovine brain tubulin was
incubated for 15min inMSBbuffer at 37C to allowMT formationstathmin (Cassimeris, 2002) as a p27 binding partner (data not
shown). To assess the importance of this interaction in vivo, (Figure 3C, first lane). The presence of 2.2 M stathmin de-
creased the polymerization rate of tubulin to 40%. This effectstathmin and p27 were cotransfected in HT-1080 cells. Coim-
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Figure 2. Inhibition of cell migration requires the
C terminus of p27 protein
A: Schematic representation of p27 deletion mu-
tants used. The binding domains for Cyclins and
CDKs and the NLS are shown in red, yellow, and
blue, respectively.
B: (Upper panels) Migrated EGFP-transfected
cells; (bottom panels) Hoechst staining identi-
fying all the migrated cells.
C and D: Percentage inhibition of HT-1080 (C)
or p27 null fibroblasts (D) transfected with EGFP-
derived vectors and allowed to migrate on FN-
coated Fluoroblok. (Insets) Expression of EGFP-
p27-fused proteins. In D, the p27-C ab raised
against p27 C terminus recognizes only p27wt.
E and F: Percentage of HT-1080 and HT-1080 p27
B7 and C9 (E) or p27/ and p27/ fibroblasts (F)
adherent to BSA (negative control), FN, VN, and
Collagen I.
G and H: Percentage of EGFP-positive HT-1080
cells adherent to 10g/ml of FN for the indicated
times (G), or to different concentration of FN for
30 min (H). Bars are SD.
was counteracted by p27wt in a dose-dependent manner (Fig- to shortening, whereas a mutant maintaining the central and
C-terminal region is able to sequester the free tubulin heterodi-ure 3C and Supplemental Figures S4D and S4E at http://www.
cancercell.org/cgi/content/full/7/1/51/DC1/), whereas the p271-170 mers, thus decreasing the MT-polymerization rate (Howell et al.,
1999). To evaluate whether p27 interfered with the catastrophe-mutant had only little effect (Figure 3C). Similarly, in a time-
dependent assay 2.2 M stathmin severely impaired the poly- promoting activity of stathmin or with its tubulin-sequestering
ability, we generated two deletion mutants, one containing themerization of tubulin (Figure 3D). p27wt alone did not significantly
interfere with this process, but when added together with stath- N-terminal portion (Stathmin1-99) and the other starting at amino
acid 25 (Stathmin25-149). An in vitro binding assay using recombi-min it completely restored the MT formation rate (Figure 3D).
As expected, p271-170 had no effect on tubulin polymerization— nant proteins revealed that p27wt (but not p271-170) was able to pull
down the stathmin25-149 deletion mutant but not the stathmin1-99neither when incubated alone (data not shown) nor in the pres-
ence of stathmin (Figure 3D). Altogether, these results clearly protein (Supplemental Figure S4C at http://www.cancercell.org/
cgi/content/full/7/1/51/DC1/). Moreover, p27wt counteracted theindicate that p27 is able to interfere with stathmin activity in vitro
and that this effect depends on the last 28 amino acids of the effects of stathmin25-149 on tubulin polymerization in a dose-
dependentmanner in an in vitro assay,whereas it was ineffectiveprotein.
It has been reported that stathmin displays two different on the activity of stathmin1-99 (Supplemental Figures S4D and
S4E), suggesting that p27 affected the stathmin tubulin seques-MT-destabilizing activities that can be discerned using deletion
mutants. The N-terminal portion retains the catastrophe-pro- tering activity. To test this hypothesis, HT-1080 cells transfected
with flag-stathmin alone or with increasing concentration of p27moting activity and stimulates the transition from MT elongation
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Figure 3. p27 binds and inhibits the MT-destabiliz-
ing protein stathmin
A: Flag IP proteins (left panels) and whole-cell
lysate (right panels) of HT-1080 cells, transfected
with the indicated vectors and analyzed for p27
and stathmin expression.
B: p27 IP of mouse embryo brain lysate probed
with anti-stathmin and anti-p27 abs.
C: In vitro tubulin polymerization assay (30 min at
37C) in the presence of the indicated recombi-
nant proteins. Polymerized MTs were separated
on SDS-PAGE gel and stained with Coomassie
blue.
D: In vitro tubulin polymerization assay performed
as a function of time.
E: Flag IP proteins (left panels) and whole-cell
lysate (right panels) of HT-1080 cells transfected
with the indicated vectors, adherent to FN for
60 min, and probed for -tubulin, p27, and flag
expression.
were allowed to adhere to FN for 1 hr. Cells were then lysed, EGFP-p27wt or EGFP-p271-170 vectors and allowed to adhere to
FN for 1 hr, acetylated MTs increased in the perinuclear regionand whole-cell lysates were used in co-IP experiments. p27
expression strongly reduced in a dose-dependent manner the of cells expressing p27wt in the cytoplasm (80% 11% of these
cells showed increasing levels of acetylated tubulins) but notinteraction of -tubulin with flag-stathmin as visualized byWest-
ern blot (Figure 3E) supporting the possibility that p27 interferes in the nucleus (15%  8%), whereas they were almost unaf-
fected by transfection with p271-170 irrespective of its localizationwith the stathmin tubulin-sequestering activity also in vivo.
(26%  10%) (Figure 4B). These data were confirmed by the
nocodazole resistance assay (Khawaja et al., 1988) in whichp27 contributes to FN-dependent MT stabilization
HT-1080 transfected with the EGFP-derived vectors wereInmouse fibroblasts adherent to FN for 30min, p27 and stathmin
treated with 2 M nocodazole for 30 min, thus specifically de-colocalized in the perinuclear region of the cells, as assessed
polymerizing dynamic MTs (Khawaja et al., 1988). Expression ofby confocal microscopy (Figure 4A). This finding suggested that
p27wt in the cytoplasm increased the number of cells containingp27 could affect MT stability by locally counteracting stathmin
acetylated MTs, whereas the p271-170 mutant slightly affectedactivity. To test this hypothesis,we took advantage of antibodies
the levels of acetylated MTs (Figures 4C and 4E). Moreover, theable to specifically recognize modified tubulins that represent
tubulin dilution assay, which distinguishes between dynamicwidely accepted markers of MT stability (Schulze et al., 1987;
and stable MTs (Khawaja et al., 1988), demonstrated that HT-Palazzo et al., 2004). In most cells, in fact, MTs can be subdi-
1080 cells contained only few stable MTs, with respect to p27-vided into dynamic MTs, which have a half-life of 5–10 min and
overexpressing cells, in which the MT network was readily ob-contain unmodified tyrosinated tubulin, and stable MTs which
persist for hours and can be identified by the content of acet- servable, as revealed by -tubulin staining (Figures 4D and 4F).
Similarly, wt fibroblasts contain more stable MTs than p27ylated or glutamylated (detyrosinated) tubulin (Schulze et al.,
1987; Palazzo et al., 2004). In HT-1080 cells transfected with null cells as evaluated by several experimental procedures. Cell
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Figure 4. p27 counteracts the stathmin MT de-
polymerization activity in vivo
A: Stathmin (green, upper panel) and p27 (red,
middle panel) colocalization (yellow, lower
panel) of mouse fibroblasts adherent to FN for
30 min.
B: Expression of the acetylated -tubulin (red)
in HT-1080 cells transfected with EGFP-p27wt or
EGFP-p271-170 vectors (green) and adherent to FN
for 90 min. Hoechst nuclear staining is shown in
blue.
C: Expression of acetylated -tubulin (red) in no-
codazole-treated cells transfected with EGFP-
p27wt or EGFP-p271-170 vectors.
D: -tubulin staining of parental or stably express-
ing p27 HT-1080 cells adherent to FN for 120 min
and then processed for tubulin dilution.
E and F: Statistical quantification of the experi-
ments showed in C and D, respectively. E: NT,
not transfected; Nuc and Cyt, nuclear or cyto-
plasmic localization of EGFP proteins. In F, 5, 15,
or 30 is the time of tubulin dilution. *p  0.005,
**p 0.007, comparing HT-1080 cells with HT-1080
p27 B7 and C9 at each time point.
lysate fractionation, which allows the separation of soluble from MT network was prominent and extended from the perinuclear
region to the periphery of the cell, with local MT accumulationcytoskeletal tubulin, demonstrated that in p27/ cells the
amount of polymerized tubulin and in particular of its glutamy- in the perinuclear region (Figure 5C, first and second columns).
By contrast, p27 null cells showed a marked reduction of fluo-lated form in FN-adherent cells was double that observed in
p27 null fibroblasts (Figure 5A, first and second panels). The rescence intensity for both glutamylated and acetylated MTs
and displayed perinuclear accumulation of modified MTs in lesstubulin dilution assay performed on cells adherent to FN for 2 hr
confirmed that p27 wt fibroblasts contained more stable MTs than 20% (19%  6%) of the cells (Figure 5C, first and second
column). No significant difference was observed for the morewith respect top27null cells, as revealedby IF (Figure 5B). Taken
together, these data strongly suggest that p27 contributes to dynamic MTs, identified using an anti-tyrosinated tubulin ab
(Figure 5C, third column). Reintroduction of p27wt in p27/ cellsMT stability, probably by interferingwith the destabilizing activity
of stathmin. in the cytoplasm resulted in increased levels and perinuclear
accumulation of modified MTs in 82%  10% of transfectedSince cell adhesion to FN contributes to the formation of
stableMTs inmouse fibroblasts (Palazzo et al., 2004), we investi- cells. When p27wt was exclusively nuclear, it had no effect on
the MT array, and the expression of cytoplasmatic p271-170 didgated the adhesion-dependent MT modifications in a p27 wt
or null background. p27/ and p27/ cells were serum starved not significantly alter MT organization (34%  15% of positive
cells showed increased expression and perinuclear accumula-for 24 hr, then allowed to adhere to FN for 120 min and analyzed
for the content of glutamylated, acetylated, or tyrosinated MTs. tion of modified MTs) as evaluated by IF using anti-acetylated
(Figure 5D) and anti-glutamylated tubulin abs (data not shown).In p27 wt fibroblasts, the glutamylated and acetylated modified
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Figure 5. p27 expression affects adhesion-
dependent MT stability in mouse fibroblasts
A: Western blot analysis of soluble (S) or cytoskel-
etal (P) tubulin fractions in p27/ and p27/ fi-
broblasts adherent to FN for 30 and 120 min. The
percentage of -tubulin (upper panel) or gluta-
mylated-tubulin (middle panel) in the cytoskele-
tal fraction (% Pol.) is reported.
B: Tubulin dilution assay of p27/ and p27/ fi-
broblasts adherent to FN for 120 min, stained for
-tubulin (green) and Hoechst (blue).
C: Staining of acetylated, glutamylated, and ty-
rosinated MTs in p27/ and p27/ fibroblasts ad-
herent for 120 min to FN.
D: Staining of acetylated MTs in p27 null cells
transfected with the indicated vectors. Scale
bar, 50 M.
Stathmin counteracts the p27-imposed (Figure 6A). Transfection with stathmin alone slightly enhanced
HT-1080 migration (Figure 6A), whereas EGFP or EGFP-p271-170migration inhibition
MT dynamics has been proposed as one of the mechanisms expression did not significantly interfere with cell migration ei-
ther in the presence or in the absence of stathmin (Figure 6A).involved in the regulation of cell migration acting either on lamel-
lipodia formation (Rodriguez et al., 2003) or on the control of Stathmin overexpression stimulated migration of p27/ fibro-
blasts, whereas it was ineffective in a p27 null backgroundcontraction and focal adhesion formation (Small et al., 2002).
To verify whether the effects of p27-stathmin interaction on MT (Figure 6B), suggesting the existence of a tight relationship be-
tween p27, stathmin, and the regulation of cell motility. Thestability were accompanied by changes in cell motility, EGFP,
EGFP-p27wt, or EGFP-p271-170 vectors were transfected in HT- stathmin25-149 construct displayed similar activity to the wt pro-
tein in stimulating cell migration (data not shown), thus implying1080 cells in the absence or in the presence of a 3-fold higher
concentration of Flag-tagged stathmin vector. Only EGFP-p27wt that tubulin sequestration is sufficient to stimulate cell migration
and that the effects of stathmin on both tubulin sequesteringwas able to inhibit cell migration toward FN, but this effect was
almost completely counteracted by coexpression of stathmin and ECM-induced cell motility are efficiently counteracted by
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Figure 6. Stathmin counteracts the p27 migration
inhibition activity
A: Migration inhibition through FN exerted by
EGFP fusion proteins transfected alone or with
Flag-stathmin in HT-1080 cells.
B: Effect of stathmin expression on the migration
of p27 wt and null fibroblasts.
C: Expression of stathmin and vinculin in parental
(), control (siC 1 and 2), and stathmin (siStath-
min 1, 2, and 3) siRNA-transfected HT-1080 cells.
D: Migration assay through FN of HT-1080 cells
treated as in C.
E: Invasion assay of HT-1080 cells transfected with
EGFP-p27wt or EGFP-p271-170 in Matrigel at 48 hr.
F and G: Matrigel evasion assay of parental or
HT-1080 p27 B7 cells cultured for 3 days (F) and
of wt and p27 null fibroblasts cultured for 5 days
(G) in complete medium. Each experiment has
been performed at least two times in quintupli-
cate.
p27. The reduction of endogenous stathmin expression by a DC1/), the difference in cell motility in 3D could not be ascribed
to different proliferation rates. In another 3D assay, HT-1080siRNA targeting stathmin mRNA (Figure 6C) resulted in a 50%
decrease of HT-1080 migration through FN (Figure 6D). Similar cells were included in Matrigel and allowed to move and exit
from the matrix. In this Matrigel evasion assay, parental cellsresults were obtained with p27 null fibroblasts and SK-LMS1
cells treated with AS ODN against stathmin (data not shown), were attracted outside Matrigel drops by serum and were con-
sistently outside after 72 hr (Figure 6F, upper panel). In the samedemonstrating that the stathmin effects on cell migration
through FN are not restricted to a single cell type. time frame, p27-stably expressing cells remained entrapped in
the matrix (Figure 6F, lower panel). No significant difference
was noticed between the various cell lines in terms of MMPp27 inhibits ECM-driven cell migration:
A three-dimensional view production (data not shown), suggesting that p27 expression
affected cell ability to move out of the Matrigel rather thanThemotile behavior of several cell typesmay vary when cultured
in a three-dimensional matrix compared to the two dimensions to degrade the ECM. Similarly, normal fibroblasts cultured in
Matrigel drops for 5 days in the presence of serum failed to exit(Sahai and Marshall, 2003), and it is likely that the 3D context
better represents what happens in living organisms. To verify from the matrix, (Figure 6G, upper panel), whereas p27 null
fibroblasts egressed quite effectively (Figure 6G, lower panel),the role of p27 in 3D migration, HT-1080 cells were transiently
transfected with p27wt or p271-170 mutant and then allowed to indicating that the absence of p27 conferred a motility advan-
tage also in a three-dimensional context.migrate in Matrigel-coated Fluorobloks for 2 days. Transfection
of HT-1080 cells with p27wt reduced to less than 50% their
invasion with respect to the p271-170 mutant (Figure 6E). Since Stathmin expression is necessary for p27-induced
migration inhibitionp27wt and p271-170 deletion mutants displayed similar effects on
cell cycle progression (Figure 2 and Supplemental Figures S2 To further confirm the importance of stathmin-p27 interaction
in the regulation of cell motility, we generated primary MEFsand S3 at http://www.cancercell.org/cgi/content/full/7/1/51/
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Figure 7. p27 fails to inhibit cell migration of stath-
min null MEFs
A: Genotype of stathmin wt and null MEFs.
B: Percentage of MEFs migrated through FN-
coated Fluorobloks.
C: Percentage of inhibition by EGFP-p27wt of
stathmin wt and null MEFs migrated through FN
for 6 hr.
D and E: RT-PCR (D) and Western blot (E) analysis
of transduced vectors in stathmin null cells. Lane
1, pMSCV; Lane 2, pMSCV-Stathmin; Lane 3,
pMSCV-p27wt; Lane 4, pMSCV-p271-170.
F: Migration assay through FN of stathmin null
MEFs treated as in E. The data ( SD) represent
the mean of two independent experiments per-
formed in duplicate.
from stathmin knockoutmice (Schubart et al., 1996). The correct by AS ODN treatment in SKLMS-1 cells increased their motility
by about 5-fold (Figure 8D), pointing to the p27/stathmin ratiogenotype of stathminwt and null MEFs was established by PCR
(Figure 7A), and cells were tested in a transwell migration assay as an important determinant in sarcoma migration.
We next analyzed the expression of p27 and stathmin in thethrough FN. Stathmin null cells migrated more slowly than wt
both at 3 and at 6 hr (Figure 7B), and EGFP-p27wt was ineffective cytoplasm and in the nucleus of ten primary and ten metastatic
tumors diagnosed as fibrosarcoma or leiomyosarcoma. In pri-in the inhibition of their motility, whereas it inhibited wt MEF
(Figure 7C). These data were further confirmed using retroviral mary tumors, p27 expression was low or absent in three out of
ten tumors and high or moderate in seven out of ten. Tumorstransduction. Stathmin null MEF, transduced with stathmin,
p27wt, or p271-170, expressed the expected mRNAs (Figure 7D) with high p27 demonstrated an expression level similar to the
surrounding normal tissue (Supplemental Figure S5A at http://and proteins (Figure 7E), but both p27wt andp271-170 were ineffec-
tive in inhibiting their migration (Figure 7F). Importantly, the www.cancercell.org/cgi/content/full/7/1/51/DC1/). Importantly, in
these tumors p27 expression was mainly localized in the cyto-motile behavior of stathmin null MEFs was rescued by stathmin
expression (Figure 7F), demonstrating that this defect was due plasm (Figure 8E and Supplemental Figure S5B). In metastatic
diseases, p27 was expressed at moderate/high levels only into the loss of stathmin functions.
four out of ten cases, and in two of them its expression was
prevalently nuclear (Figure 8E and Supplemental Figure S5B).The p27/stathmin expression ratio correlates
with sarcoma cell migration and tumor Stathmin expression was present at moderate/high levels in
four primary tumors and at low levels in six cases, whereas itmetastasis formation
Emerging evidences indicate that in cells of mesenchymal origin was high in eight and low in two cases of metastatic diseases
(Figure 8E).When the cytoplasmic p27/stathmin ratiowas calcu-like fibroblasts or fibrosarcomas (this work), smooth muscle
(Sun et al., 2001), endothelial (Goukassian et al., 2001), and lated it became clear that primary sarcomas showed a high
ratio (	1) in nine out of ten cases, whereas metastatic diseasesmesangial cells (Daniel et al., 2004) p27 acts as inhibitor of cell
migration and/or invasion. Thus, we extended our analysis to always displayed a ratio1 (Figure 8F), supporting the possibil-
ity that changes in the levels of cytoplasmic p27 and stathminthree other leiomyosarcoma (SKUT-1, SKLMS-1, andMES-SA)-
and one fibrosarcoma (HS-913T)-derived cell lines. The expres- contribute to metastases development in human sarcomas.
sion levels of stathmin and p27 were evaluated by Western blot
(Figure 8A), and the ratio between p27 and stathmin correlated Discussion
with the ability of tumor cells to migrate through FN-coated
Fluorobloks (Figure 8B). SKUT-1 cells that expressed the lowest ECM-dependent interaction between stathmin and p27
Here, we provide experimental evidences unveiling a previouslyp27/stathmin ratio migrated at the fastest rate, whereas MES-
SA, which displayed the highest ratio, migrated more slowly unknown function of p27 and stathmin in the regulation of cell
motility and supporting the idea thatMTdynamics plays a crucialthan the other cell lines. Moreover, SKUT-1 cells stably trans-
fected with p27 showed more than 50% decrease in cell migra- role in the control of cell motility through or within the ECM.
Our data demonstrate that cell-ECM contact, inducing a prompttion rate through FN (Figure 8C), whereas decreasing p27 levels
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Figure 8. The p27/stathmin ratio correlates with
cell migration capacity and tumor metastasis
formation in human sarcomas
A: Stathmin and p27 proteins expression in four
sarcoma-derived cell lines. -tubulin was used as
loading control.
B: Percentage of sarcoma cells migrated for 6
hr through FN.
C: Percentage of parental SKUT-1 and two p27-
expressing clones migrated for 18 hr through FN.
(Inset) p27 and -tubulin expression.
D: Percentage of migrated SKLMS-1 cells treated
for 48 hr with ODN missense (MS) or antisense
(AS) against p27 for 8 hr through FN. (Inset) p27
and vinculin expression.
E: Expression of p27 and stathmin in nuclear (N)
and cytoplasmic (C) extracts derived from pri-
mary or metastatic sarcomas. -tubulin and his-
tone H1 were used as control for the cytoplasmic
and nuclear fractions, respectively.
F: Cytoplasmic p27/stathmin ratio in ten primary
and ten metastatic diseases. The median value
is shown. p 
 0.001 (Student’s t test). Error bars
are SD.
p27 nucleocytoplasmic shuttling, favors p27-stathmin interac- CDK2, and its phosphorylation seems to affect cell motility (Niet-
hammer et al., 2004). It is also possible, and this is a matter fortion. This interaction, in turn, influences cell motility, thus de-
termining a tight link between regulation of cell proliferation and future studies, that p27 binding to CDK1 and 2 could contribute
to the modulation of stathmin phosphorylation, eventually lead-cell movement. Interestingly, a recent report (Boehm et al., 2002)
describes the interaction between p27 and Kinase Interacting ing to an altered cell motility.
with Stathmin (KIS; Maucuer et al., 1997), supporting the exis-
tence of a macromolecular complex governing p27-stathmin Role of stathmin in cell motility
functions. KIS activation, due to growth factor stimulation, in- Our data suggest that modulation of MT stability in cells in
duces p27 phosphorylation on serine 10 and contributes to its contact with and moving through or within ECM substrates by
shuttling from the nucleus to the cytoplasm (Boehm et al., 2002), p27/stathmin interaction could represent an important pathway
where p27 loses its growth inhibitory activity but can still interact linking proliferation and motility. In line with these observations,
with stathmin. Whether p27 cytoplasmic delocalization due to we propose stathmin as a pivotal regulator of cell migration.
cell adhesion to ECM is dependent, at least in part, on KIS This is based on several observations: first, stathmin null MEFs
activity is still matter of speculation. The analysis of p27 deletion migrated more slowly than the wt cells through FN, and this
mutants revealed that the cyclin-cdk binding domain as well as phenotype was reversed by stathmin reintroduction. Second,
stathmin downregulation in sarcoma-derived cell lines deter-the last 28 amino acids of p27 are necessary for its motility
inhibition activity. It is of note that the C-terminal portion of p27 mined a strong migration inhibition, whereas its overexpression
increased FN-directed motility. These observations could beis highly conserved from Xenopus to humans, suggesting that
the mechanism that we describe here could be retained along of particular interest for cancer cells where stathmin is often
upregulated and in which its role has not yet been fully eluci-the evolution. Moreover, stathmin is a substrate of CDK1 and
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dated (for a review, seeCurmi et al., 1999). Third, stathmin is also in vitro assays, like wound healing. AlteredMT dynamics impairs
the direction of cell motility in this assay, resulting either inexpressed at high levels in brain and testis, and it is interesting to
note that inDrosophila (in which, differently frommammals, only reduced cell migration (Liao et al., 1995) or in altered trajectories
in the wound (Kodama et al., 2003). Thus, it is possible thatone stathmin-related gene is present) stathmin downregulation
is accompanied by defective migration of germ cells and altered p27, contributing to stabilize the perinuclear network of MTs,
enforces cell polarity and favors the movements of highly polar-neurite elongation (Ozon et al., 2002). Finally, inhibition of stath-
min expression impaired neurons’ migration in rats (Jin et al., ized cells. Our preliminary results indicated that this is the case
in p27 null fibroblasts during wound healing assay, since they2004), demonstrating that this protein plays a pivotal role in cell
motility also in vivo. migrated toward the wounded area with altered cell trajectories
and failed to reorient glutamylated MTs to the scratched area
(unpublished data). Interestingly, while this manuscript was inp27-stathmin interaction influences the MT stability
We demonstrated that stathmin MT depolymerization activity preparation, Roberts and colleagues reported that p27 expres-
sion stimulates wound healing cell motility by decreasing theis well counteracted in vitro and in vivo by p27. Our data support
the possibility that p27 interferes with the ability of stathmin to RhoA-Rock1 activity (Besson et al., 2004), a pathway known to
be necessary for amoeboid cell migration (Sahai and Marshall,sequester the free tubulin heterodimers, and this function seems
to affect interphaseMTs rather than themitotic spindle catastro- 2003). The inhibitory role played by p27 in the regulation of
cell motility may be of particular relevance in tumor cells thatphe (Holmfeldt et al., 2001). Although we cannot exclude the
possibility that other proteins interact with p27 to modulate its frequently use amoeboidmovements to invade andmetastasize
(Condeelis and Segall, 2003) and in which stathmin is oftenactivity on cell motility, the finding that p27 does not inhibit
migration of stathmin null cells suggests that stathmin is the upregulated.
principal p27 target for this activity. The effects of p27/stathmin
interaction on FN- or VN-driven cell motility seem to be directly Role of p27 and stathmin in tumor progression
In a wide variety of human cancers, p27 downregulation haslinked to the modulation of FN-dependent MT stability, since
p27 expression restores the content of stable MTs in p27 null been linked to a worse prognosis, increased recurrence of local
disease, and a higher incidence of local invasion or distantfibroblasts or in HT-1080 cells. Thus, our data provide evidence
for the existence of an intracellular pathway inducingMTstability metastasis (reviewed in Slingerland and Pagano, 2000). More
recently, it has been proposed that the subcellular localizationfollowing adhesion to ECM substrates, an observation recently
suggested by Gundersen and colleagues (Palazzo et al., 2004). of p27 is also important in tumor formation and/or progression,
since its cytoplasmic displacement results in a loss of functionThe different distribution of stable modified MTs in p27 wt
versus null fibroblasts suggests that p27/stathmin perinuclear related to cell cycle progression inhibition (Blain et al., 2003).
On the other hand, cytoplasmic localization of p27 in thyroidinteraction (Figure 4A) contributes to locally determine the stabil-
ity of the MT cytoskeleton. In accord with this hypothesis, it has (Baldassarre et al., 1999b) and in mammary carcinomas (Liang
et al., 2002) has been associated with lower malignancy in com-been demonstrated that migrating cells display a fine regional
regulation of MT dynamics (Wadsworth, 1999) that, at least in parison with p27 absence. The present finding that p27 cyto-
plasmic expression inhibitsmigration and invasion of tumor cellspart, could be assured by the regulation of stathmin functions.
can at least in part explain this latter observation and is in
accordwith the finding that in sarcoma samples low cytoplasmicThe contrasted role of p27 in cell motility
p27 has been alternatively reported as inhibitor (Sun et al., 2001; expression of p27 and high stathmin levels correlate with distant
metastasis formation. Importantly, it has been demonstratedGoukassian et al., 2001; Daniel et al., 2004) or stimulator
(McAllister et al., 2003) of cell migration in primary or stabilized that in a mouse model of sarcomas the absence of p27 but not
p21 was able to increase the number of metastatic sarcomascells of different origins, leaving the role of p27 in cell motility
still open (Assoian, 2004). We propose that the present study and to shorten their time of appearance (Martin-Caballero et
al., 2004).could reconcile the apparent controversial role depicted for p27,
based on its activity on MT dynamics. The major difference Stathmin is expressed and could influence time to progres-
sion in metastatic non-small cell lung cancer (Rosell et al., 2003)between the reports suggesting an inhibitory role for p27 in cell
motility and the works that support a promigratory role of p27 and is associated with the more aggressive phenotype in Wilms
tumors (Takahashi et al., 2002). Similarly, we found that in sarco-is, in our opinion, the type of cellmotility assayed.Cellsmigrating
through the pores of FN-coated transwell or in 3D and in vivo mas stathmin expression is higher in metastatic than in primary
tumors. Moreover, the fact that p27 cytoplasmic expressioncan use amoeboidmovements that respond to attractant stimuli
lacking an obvious polarization (Webb and Horwitz, 2003), as- contributes to MT stabilization should be taken into account
when using tubulin-acting agents in cancer therapy. p27 influ-sume a roundish/elliptoid morphology, and are largely depen-
dent on propulsive forces and on cytoplasmic streaming for ences the response to taxol in 3D cultured cancer cells (St.
Croix et al., 1996) and probably in patients (Van Poznak et al.,their motility (Friedl and Wolf, 2003). In this case, p27 could act
as an inhibitor of cell migration by altering MT stability, thus 2002). Similarly, stathmin expression has been correlated with
the resistance to MT-acting drugs in cultured cells (Alli et al.,impairing the generation of propulsive forces and/or the cy-
toskeletal modifications necessary for the cell to move. Accord- 2002) as well as in patients with non-small cell lung cancer
metastasis (Rosell et al., 2003). In summary, this study opensingly, p27 null smooth muscle cells’ migration in transwell is
fully inhibited by the MT-stabilizing drug taxol (Sun et al., 2001), a window on the molecular mechanisms contributing to the
regulation of cancer cell invasion and represents another stepwhich acts downstream of p27-stathmin functions on MT dy-
namics. Conversely, MT stability has been proposed as one of toward the comprehension of the relationship existing between
proliferation and motility in mammalian cells.the mechanisms contributing to a proper directional motility in
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